UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The use of novel drugs can effectively improve response, delay relapse and enhance overall survival in multiple myeloma patients with renal impairment

PloS one, 2014-07, Vol.9 (7), p.e101819-e101819

2014

Volltextzugriff (PDF)

Allogeneic haematopoietic stem cell transplantation : current status and future outlook

British medical bulletin, 2006-01, Vol.77-78 (1), p.23-36

ASCHAN, Johan

2006

Volltextzugriff (PDF)

Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2007-12, Vol.40 (11), p.1055-1062

2007

Volltextzugriff (PDF)

A prospective randomized toxicity study to compare reduced‐intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation

Journal of internal medicine, 2013-08, Vol.274 (2), p.153-162

2013

Volltextzugriff (PDF)

P1443: AUTOLOGOUS NK CELLS AS CONSOLIDATION AFTER FRONT‐LINE STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA: A LONG‐TERM FOLLOW‐UP

HemaSphere, 2022-06, Vol.6 (Suppl), p.1326-1327

2022

Volltextzugriff (PDF)

A retrospective comparison of conventional intensity conditioning and reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in myelofibrosis

Bone marrow transplantation (Basingstoke), 2009-09, Vol.44 (5), p.317-320

2009

Volltextzugriff (PDF)

Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT

Bone marrow transplantation (Basingstoke), 2007-11, Vol.40 (9), p.865-869

2007

Volltextzugriff (PDF)

Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study

Immunotherapy, 2009-09, Vol.1 (5), p.753-764

2009

Volltextzugriff (PDF)

Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation

Leukemia, 2001-12, Vol.15 (12), p.1976-1985

2001

Volltextzugriff (PDF)

Follow up of multiple myeloma patients with renal impairment during a 10 year period

HAEMATOLOGICA, 2012, Vol.97, p.599

2012

Volltextzugriff (PDF)

Is multiple myeloma a chronic disease?

HAEMATOLOGICA, 2012, Vol.97, p.345

2012

Volltextzugriff (PDF)

Impact on the cytomegalovirus (CMV) viral load by CMV-specific T-cell immunity in recipients of allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2006-11, Vol.38 (10), p.687-692

2006

Volltextzugriff (PDF)

Bortezomib, response and retreatment in 1st, 2nd, 3rd and 4th line of treatment in patients with multiple myeloma

HAEMATOLOGICA, 2012, Vol.97, p.610

2012

Volltextzugriff (PDF)

Treatment Sequencing Survival Model for Patients with Multiple Myeloma Ineligible for Stem Cell Transplantation (SCT)

Value in health, 2014-11, Vol.17 (7), p.A617-A618

2014

Volltextzugriff (PDF)

Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease

Transplantation, 2006-05, Vol.81 (10), p.1390

2006

Volltextzugriff (PDF)

The effect of metronidazole on busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2003-03, Vol.31 (6), p.429-435

2003

Volltextzugriff (PDF)

G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV

Bone marrow transplantation (Basingstoke), 2003-07, Vol.32 (2), p.217-223

2003

Volltextzugriff (PDF)

Evaluation of immune responses to seasonal influenza vaccination in healthy volunteers and in patients after stem cell transplantation

Transplantation, 2008-07, Vol.86 (2), p.257-263

2008

Volltextzugriff (PDF)

Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis

Bone marrow transplantation (Basingstoke), 1998-10, Vol.22 (8), p.755-761

1998

Volltextzugriff (PDF)

Low-dose ARAC, donor cells, and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantation

Leukemia, 2004-08, Vol.18 (8), p.1430-1433

2004

Volltextzugriff (PDF)

Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipients

Bone marrow transplantation (Basingstoke), 2004-12, Vol.34 (12), p.1067-1069

2004

Volltextzugriff (PDF)

Treatment of moderate to severe acute graft-versus-host disease : a retrospective analysis

Bone marrow transplantation (Basingstoke), 1994-10, Vol.14 (4), p.601-607

ASCHAN, J

1994

Volltextzugriff (PDF)

A ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Mantle Cell Lymphoma (MCL) Cells

Pharmaceutics, 2022-10, Vol.14 (10), p.2238

2022

Volltextzugriff (PDF)

OuaSelect, a novel ouabain-resistant human marker gene that allows efficient cell selection within 48 h

Gene therapy, 2007-11, Vol.14 (22), p.1564-1572

2007

Volltextzugriff (PDF)

N-acetyl-L-cysteine does not affect the pharmacokinetics or myelosuppressive effect of busulfan during conditioning prior to allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2003-08, Vol.32 (4), p.349-354

2003

Volltextzugriff (PDF)

1 – 25 von 242

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(209)
Mit Volltextzugriff
(189)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(119)
Medicin Och Hälsovetenskap
(119)
Science & Technology
(113)
Life Sciences & Biomedicine
(107)
Adult
(87)
Biological And Medical Sciences
(81)
Medical Sciences
(80)
Middle Aged
(75)
Male
(70)
Female
(68)
Transplantation
(66)
Immunology
(56)
Adolescent
(53)
Hematology
(51)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(47)
Child
(47)
Transfusions. Complications. Transfusion Reactions. Cell And Gene Therapy
(46)
Bone Marrow, Stem Cells Transplantation. Graft Versus Host Reaction
(44)
Child, Preschool
(37)
Oncology
(32)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The use of novel drugs can effectively improve response, delay relapse and enhance overall survival in multiple myeloma patients with renal impairment

Allogeneic haematopoietic stem cell transplantation : current status and future outlook

Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation

A prospective randomized toxicity study to compare reduced‐intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation

P1443: AUTOLOGOUS NK CELLS AS CONSOLIDATION AFTER FRONT‐LINE STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA: A LONG‐TERM FOLLOW‐UP

A retrospective comparison of conventional intensity conditioning and reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in myelofibrosis

Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT

Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study

Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation

Follow up of multiple myeloma patients with renal impairment during a 10 year period

Is multiple myeloma a chronic disease?

Impact on the cytomegalovirus (CMV) viral load by CMV-specific T-cell immunity in recipients of allogeneic stem cell transplantation

Bortezomib, response and retreatment in 1st, 2nd, 3rd and 4th line of treatment in patients with multiple myeloma

Treatment Sequencing Survival Model for Patients with Multiple Myeloma Ineligible for Stem Cell Transplantation (SCT)

Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease

The effect of metronidazole on busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation

G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV

Evaluation of immune responses to seasonal influenza vaccination in healthy volunteers and in patients after stem cell transplantation

Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis

Low-dose ARAC, donor cells, and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantation

Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipients

Treatment of moderate to severe acute graft-versus-host disease : a retrospective analysis

A ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Mantle Cell Lymphoma (MCL) Cells

OuaSelect, a novel ouabain-resistant human marker gene that allows efficient cell selection within 48 h

N-acetyl-L-cysteine does not affect the pharmacokinetics or myelosuppressive effect of busulfan during conditioning prior to allogeneic stem cell transplantation

Suchergebnisse filtern